COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies.

Brodard, Justine; Kremer Hovinga, Johanna A; Fontana, Pierre; Studt, Jan-Dirk; Gruel, Yves; Greinacher, Andreas

Brodard, Justine; Kremer Hovinga, Johanna A; Fontana, Pierre; Studt, Jan-Dirk; Gruel, Yves; Greinacher, Andreas.

Afiliação

Brodard J; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Kremer Hovinga JA; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Fontana P; Division of Angiology and Haemostasis, University Hospitals of Geneva, Geneva, Switzerland.
Studt JD; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
Gruel Y; Department of Hematology-Hemostasis, University Hospital of Tours, Tours, France.
Greinacher A; Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.

J Thromb Haemost ; 19(5): 1294-1298, 2021 05.

Article em En | MEDLINE | ID: mdl-33550713

Assuntos

COVID-19; Heparina; Anticoagulantes; Plaquetas; Heparina/efeitos adversos; Humanos; Imunoglobulina G; Fator Plaquetário 4; SARS-CoV-2

Palavras-chave

COVID-19; heparin; platelet factor 4; thrombocytopenia; thrombosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heparina / COVID-19 Limite: Humans Idioma: En Revista: J Thromb Haemost Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google